Munich - Delayed Quote EUR
China Resources Pharmaceutical Group Ltd (640.MU)
0.5550
0.0000
(0.00%)
At close: April 29 at 8:04:09 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
257,673,256
257,673,256
244,703,884
218,182,994
193,564,322.6422
Cost of Revenue
216,984,387
216,984,387
206,366,398
184,563,943
164,644,632.2329
Gross Profit
40,688,869
40,688,869
38,337,486
33,619,051
28,919,690.4092
Operating Expense
26,883,603
26,883,603
25,510,780
20,752,577
18,203,556.3272
Operating Income
13,805,266
13,805,266
12,826,706
12,866,474
10,716,134.0820
Net Non Operating Interest Income Expense
-1,600,779
-1,600,779
-1,798,626
-1,732,289
-1,647,339.8747
Pretax Income
10,929,922
10,929,922
9,880,227
8,361,081
6,873,015.3924
Tax Provision
2,526,679
2,526,679
2,105,224
1,703,152
1,439,454.9191
Net Income Common Stockholders
3,350,857
3,350,857
3,854,247
3,500,270
3,080,673.3181
Diluted NI Available to Com Stockholders
3,350,857
3,350,857
3,854,247
3,500,270
3,080,673.3181
Basic EPS
0.53
--
0.61
0.56
0.49
Diluted EPS
0.53
--
0.61
0.56
0.49
Basic Average Shares
6,282,510.4610
--
6,282,510.4610
6,282,510.4610
6,282,510.4610
Diluted Average Shares
6,282,510.4610
--
6,282,510.4610
6,282,510.4610
6,282,510.4610
Rent Expense Supplemental
--
--
138,610
136,336
--
Total Expenses
243,867,990
243,867,990
231,877,178
205,316,520
182,848,188.5602
Net Income from Continuing & Discontinued Operation
3,350,857
3,350,857
3,854,247
3,500,270
3,080,673.3181
Normalized Income
4,690,600.3022
4,690,600.3022
5,160,646.8057
4,463,129.7013
3,979,325.8279
Interest Income
681,103
681,103
587,686
721,177
596,150.3219
Interest Expense
2,281,882
2,281,882
2,386,312
2,453,466
2,243,490.1965
Net Interest Income
-1,600,779
-1,600,779
-1,798,626
-1,732,289
-1,647,339.8747
EBIT
13,211,804
13,211,804
12,266,539
10,814,547
9,116,505.5890
EBITDA
16,568,514
16,568,514
15,430,904
13,372,988
11,423,106.0831
Reconciled Cost of Revenue
216,984,387
216,984,387
206,366,398
184,563,943
164,644,632.2329
Reconciled Depreciation
3,356,710
3,356,710
3,164,365
2,558,441
2,306,600.4941
Net Income from Continuing Operation Net Minority Interest
3,350,857
3,350,857
3,854,247
3,500,270
3,080,673.3181
Total Unusual Items Excluding Goodwill
-1,622,617
-1,622,617
-1,554,894
-1,102,250
-1,008,770.8077
Total Unusual Items
-1,530,389
-1,530,389
-1,472,080
-1,017,112
-907,616.4664
Normalized EBITDA
18,098,903
18,098,903
16,902,984
14,390,100
12,330,722.5494
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-375,101.6978
-375,101.6978
-331,308.1943
-224,528.2987
-211,272.6392
12/31/2021 - 2/8/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade